title: Succinct review of the new VTE prevention and management guidelines.
abstract: Venous thromboembolism is a major source of morbidity and mortality in the United States. The American College of Chest Physicians Antithrombotic Guidelines, 9th edition, includes a large number of clinical practice recommendations regarding the diagnosis, treatment, and prevention of venous thromboembolism. This succinct clinical review of these guidelines specifically focuses on the evaluation, treatment, and prevention of venous thromboembolic disease.
authors.affiliation: Division of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
authors.forename: Amy West
authors.initials: AW
authors.lastname: Pollak
authors.affiliation: Division of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. Electronic address: mcbane.robert@mayo.edu.
authors.forename: Robert D
authors.initials: RD
authors.lastname: McBane
mesh_terms: D000553:Ambulatory Care; D000925:Anticoagulants / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D012307:Risk Factors; D012955:Societies, Medical / Q000592:standards; D014481:United States; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D020246:Venous Thrombosis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents